IN2013MU03389A - - Google Patents

Info

Publication number
IN2013MU03389A
IN2013MU03389A IN3389MU2013A IN2013MU03389A IN 2013MU03389 A IN2013MU03389 A IN 2013MU03389A IN 3389MU2013 A IN3389MU2013 A IN 3389MU2013A IN 2013MU03389 A IN2013MU03389 A IN 2013MU03389A
Authority
IN
India
Prior art keywords
layer
pharmaceutically acceptable
acceptable excipients
ingredients
active
Prior art date
Application number
Other languages
English (en)
Inventor
Girish Kumar Jain
Ramakant Kashinath Gundu
Rahul Sudhakar Dabre
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3389MU2013 priority Critical patent/IN2013MU03389A/en
Publication of IN2013MU03389A publication Critical patent/IN2013MU03389A/en

Links

IN3389MU2013 2008-03-19 2013-10-28 IN2013MU03389A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3389MU2013 IN2013MU03389A (pt) 2008-03-19 2013-10-28

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN558MU2008 2008-03-19
IN3389MU2013 IN2013MU03389A (pt) 2008-03-19 2013-10-28

Publications (1)

Publication Number Publication Date
IN2013MU03389A true IN2013MU03389A (pt) 2015-07-17

Family

ID=54397432

Family Applications (2)

Application Number Title Priority Date Filing Date
IN3389MU2013 IN2013MU03389A (pt) 2008-03-19 2013-10-28
IN3390MU2013 IN2013MU03390A (pt) 2008-03-19 2013-10-28

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN3390MU2013 IN2013MU03390A (pt) 2008-03-19 2013-10-28

Country Status (1)

Country Link
IN (2) IN2013MU03389A (pt)

Also Published As

Publication number Publication date
IN2013MU03390A (pt) 2015-07-17

Similar Documents

Publication Publication Date Title
WO2008146178A3 (en) A novel tablet dosage form
MX2009004871A (es) Paquete de dosificacion unitaria y metodos para administrar medicaciones de perdida de peso.
PH12015501595A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
PH12015501598A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MX2012003082A (es) Composiciones farmaceuticas para reducir la absorcion rapida de la dosis inducida por el alcohol.
RS52831B (en) THIN BUPRENORPHINE TILES FOR DRUG REPLACEMENT THERAPY
PH12015501600A1 (en) Spiro-lactam nmda receptor modulators and uses thereof
MX363495B (es) Proceso de manufacturacion de una forma de dosificacion multifasica de rapida disolucion liofilizada.
MY188450A (en) Spiro-lactam nmda receptor modulators and uses thereof
SG194756A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
PH12014501408A1 (en) Immediate release multi unit pellet system
MX359288B (es) Forma iv del clorhidrato de ivabradina.
WO2012145575A3 (en) Therapy for leukemia
TN2015000135A1 (en) Modified release formulations for oprozomib
MX2021004883A (es) Metodos y composiciones para tratar apnea del sue?o.
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
PH12015500395A1 (en) Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
IN2013MU03389A (pt)
WO2016091805A3 (de) Naloxon-monopräparat und mehrschichttablette
WO2011126327A3 (en) Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof
WO2013054178A3 (en) Extended release pharmaceutical compositions containing carmabazepine
WO2012080984A3 (es) Comprimido farmacéutico de liberación controlada para administración oral
MX2011005899A (es) Composicion farmacéutica con antihistamínico no sedante y combinaciones.
WO2014155268A3 (en) Fgf-r tyrosine kinase activity inhibitors - use in diseases associated with lack of or reduced snf5 activity
MX2017014725A (es) Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.